United States Pharmaceuticals

Hims & Hers Health Inc (HIMS)

Hims & Hers Health experienced twenty-five insider trading transactions over the past ninety days, all involving sales totaling approximately 7.6 million dollars. Key executives, including the CFO and Chief Legal Officer, executed these planned divestments. This activity follows a recent earnings report that missed expectations, occurring while the stock price remains well below its annual peak.
Ticker: HIMS Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Hims & Hers Health Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.3
Boughton Soleil Chief Legal Officer Officer
Transaction date
Planned sale
Price
226.80
Quantity 31,389 -20.0%
Value US$4,498,168
3.3
Boughton Soleil Officer Officer
Transaction date
Proposed sale
Price
378.38
Quantity 16,116
Value US$1,909,134
3.3
Boughton Soleil Chief Legal Officer Officer
Transaction date
Planned sale
Price
473.08
Quantity 4,084 -16.8%
Value US$34,934
3.3
Boughton Soleil Officer Officer
Transaction date
Proposed sale
Price
29.06
Quantity 3,461
Value US$100,577
3.3
Okupe Oluyemi Chief Financial Officer Officer
Transaction date
Planned sale
Price
29.70
Quantity 2,000 -0.8%
Value US$59,400
3.3
Okupe Oluyemi Officer Officer
Transaction date
Proposed sale
Price
29.70
Quantity 2,000
Value US$59,400
3.3
Boughton Soleil Chief Legal Officer Officer
Transaction date
Planned sale
Price
29.17
Quantity 3,461 -1.1%
Value US$100,957
3.3
Boughton Soleil Officer Officer
Transaction date
Proposed sale
Price
29.17
Quantity 3,461
Value US$100,957
3.3
Okupe Oluyemi Chief Financial Officer Officer
Transaction date
Planned sale
Price
29.95
Quantity 29,277 -11.0%
Value US$876,846
3.3
Okupe Oluyemi Officer Officer
Transaction date
Proposed sale
Price
29.95
Quantity 29,277
Value US$876,846
3.3
Okupe Oluyemi Chief Financial Officer Officer
Transaction date
Planned sale
Price
28.82
Quantity 12,313 -4.7%
Value US$354,861
3.3
Okupe Oluyemi Officer Officer
Transaction date
Proposed sale
Price
28.82
Quantity 12,313
Value US$354,861
3.3
Boughton Soleil Chief Legal Officer Officer
Transaction date
Planned sale
Price
27.86
Quantity 6,236 -2.0%
Value US$173,735
3.3
Boughton Soleil Officer Officer
Transaction date
Proposed sale
Price
27.86
Quantity 6,236
Value US$173,735
0.5
Chi Michael Chief Operating Officer Officer
Transaction date
Planned sale
Price
28.39
Quantity 14,027 -3.0%
Value US$398,227
Elshenawy Mohamed CTO Officer
Transaction date
Planned sale
Price
28.39
Quantity 7,954 -4.1%
Value US$225,814
Elshenawy Mohamed Officer Officer
Transaction date
Proposed sale
Price
28.39
Quantity 7,954
Value US$225,814
0.5
Chi Michael Officer Officer
Transaction date
Proposed sale
Price
28.39
Quantity 14,027
Value US$398,227
3.3
Boughton Soleil Chief Legal Officer Officer
Transaction date
Planned sale
Price
28.33
Quantity 3,458 -1.1%
Value US$97,965
3.3
Boughton Soleil Officer Officer
Transaction date
Proposed sale
Price
28.33
Quantity 3,458
Value US$97,965
3.3
Okupe Oluyemi Chief Financial Officer Officer
Transaction date
Planned sale
Price
29.99
Quantity 4,938 -1.8%
Value US$148,111
3.3
Boughton Soleil Chief Legal Officer Officer
Transaction date
Planned sale
Price
27.55
Quantity 25,111 -7.4%
Value US$691,808
3.3
Boughton Soleil Officer Officer
Transaction date
Proposed sale
Price
27.55
Quantity 25,111
Value US$691,808
1.8
Autor Deborah M. Chief Policy Officer Executive Director
Transaction date
Planned sale
Price
27.85
Quantity 16,773 -25.5%
Value US$467,128
1.8
Autor Deborah M. Officer; Director Executive Director
Transaction date
Proposed sale
Price
27.85
Quantity 16,773
Value US$467,128
3.3
Okupe Oluyemi Chief Financial Officer Officer
Transaction date
Planned sale
Price
27.89
Quantity 9,388 -3.4%
Value US$261,802
2.1
Pendarvis Christiane Former Director Non-Executive Director
Transaction date
Proposed sale
Price
32.37
Quantity 3,500
Value US$113,278
3.3
Okupe Oluyemi Chief Financial Officer Officer
Transaction date
Planned sale
Price
31.99
Quantity 7,163 -2.5%
Value US$229,168
3.3
Okupe Oluyemi Chief Financial Officer Officer
Transaction date
Planned sale
Price
36.49
Quantity 7,163 -2.5%
Value US$261,351
3.3
Oluyemi Okupe Officer Officer
Transaction date
Proposed sale
Price
38.28
Quantity 28,652
Value US$1,096,799
3.3
Okupe Oluyemi Chief Financial Officer Officer
Transaction date
Planned sale
Price
34.03
Quantity 18,197 -6.0%
Value US$619,217
3.3
Okupe Oluyemi Chief Financial Officer Officer
Transaction date
Planned sale
Price
35.09
Quantity 55,383 -19.5%
Value US$1,943,389
3.6
Carroll Patrick Harrison Chief Medical Officer Officer
Transaction date
Sale
Price
35.00
Quantity 23,726 -11.5%
Value US$830,410
3.6
Carroll Patrick Harrison Officer Officer
Transaction date
Proposed sale
Price
35.00
Quantity 23,726
Value US$830,410
2.4
Becklund Irene PAO Officer
Transaction date
Planned sale
Price
31.50
Quantity 4,490 -39.8%
Value US$141,435
0.5
Chi Michael Chief Operating Officer Officer
Transaction date
Planned sale
Price
31.50
Quantity 14,027 -3.1%
Value US$441,850
Elshenawy Mohamed CTO Officer
Transaction date
Planned sale
Price
31.50
Quantity 30,040 -22.9%
Value US$946,260
2.4
Becklund Irene Officer Officer
Transaction date
Proposed sale
Price
31.50
Quantity 4,490
Value US$141,435
Elshenawy Mohamed Officer Officer
Transaction date
Proposed sale
Price
31.50
Quantity 30,040
Value US$946,260
0.5
Chi Michael Officer Officer
Transaction date
Proposed sale
Price
31.50
Quantity 14,027
Value US$441,850
2.4
Becklund Irene PAO Officer
Transaction date
Planned sale
Price
30.25
Quantity 7,573 -40.2%
Value US$229,083
2.4
Becklund Irene Officer Officer
Transaction date
Proposed sale
Price
30.25
Quantity 7,573
Value US$229,083
2.8
WELLS DAVID B Non-Executive Director
Transaction date
Purchase
Price
24.24
Quantity 48,400 +27.5%
Value US$1,172,974
3.3
Okupe Oluyemi Chief Financial Officer Officer
Transaction date
Planned sale
Price
23.64
Quantity 7,950 -2.9%
Value US$187,916
3.3
Boughton Soleil Chief Legal Officer Officer
Transaction date
Planned sale
Price
30.00
Quantity 9,463 -3.1%
Value US$283,890
3.3
Okupe Oluyemi Chief Financial Officer Officer
Transaction date
Planned sale
Price
29.96
Quantity 19,645 -7.0%
Value US$588,615
3.3
Boughton Soleil Officer Officer
Transaction date
Proposed sale
Price
30.00
Quantity 9,463
Value US$283,890
3.3
Okupe Oluyemi Chief Financial Officer Officer
Transaction date
Planned sale
Price
27.83
Quantity 18,005 -6.3%
Value US$501,158
3.3
Okupe Oluyemi Chief Financial Officer Officer
Transaction date
Planned sale
Price
25.90
Quantity 36,922 -11.6%
Value US$956,147
3.3
Okupe Oluyemi Chief Financial Officer Officer
Transaction date
Planned sale
Price
19.98
Quantity 3,975 -1.2%
Value US$79,409
3.3
Oluyemi Okupe Officer Officer
Transaction date
Proposed sale
Price
20.33
Quantity 240,560
Value US$4,890,585
3.3
Okupe Oluyemi Chief Financial Officer Officer
Transaction date
Planned sale
Price
23.77
Quantity 9,217 -2.8%
Value US$219,067
3.3
Boughton Soleil Chief Legal Officer Officer
Transaction date
Planned sale
Price
24.69
Quantity 4,812 -1.5%
Value US$118,808
2.4
Becklund Irene PAO Officer
Transaction date
Planned sale
Price
24.69
Quantity 5,529 -38.7%
Value US$136,511
0.5
Chi Michael Chief Operating Officer Officer
Transaction date
Planned sale
Price
24.69
Quantity 97,289 -19.3%
Value US$2,402,065
3.3
Boughton Soleil Officer Officer
Transaction date
Proposed sale
Price
24.69
Quantity 4,812
Value US$118,808
2.4
Becklund Irene Officer Officer
Transaction date
Proposed sale
Price
24.69
Quantity 5,529
Value US$136,511
0.5
Chi Michael Officer Officer
Transaction date
Proposed sale
Price
24.69
Quantity 97,289
Value US$2,402,065
3.3
Boughton Soleil Chief Legal Officer Officer
Transaction date
Planned sale
Price
15.21
Quantity 4,651 -1.0%
Value US$70,742
3.3
Boughton Soleil Officer Officer
Transaction date
Proposed sale
Price
15.21
Quantity 4,651
Value US$70,742
3.3
Okupe Oluyemi Chief Financial Officer Officer
Transaction date
Sale
Price
26.44
Quantity 5,262 -5.4%
Value US$139,108
3.3
Okupe Oluyemi Chief Financial Officer Officer
Transaction date
Sale
Price
26.44
Quantity 5,262 -5.4%
Value US$139,108
3.3
Okupe Oluyemi Chief Financial Officer Officer
Transaction date
Sale
Price
30.34
Quantity 9,067 -9.0%
Value US$275,114
3.3
Oluyemi Okupe Officer Officer
Transaction date
Proposed sale
Price
30.47
Quantity 27,204
Value US$828,906
3.3
Okupe Oluyemi Chief Financial Officer Officer
Transaction date
Planned sale
Price
33.79
Quantity 9,070 -9.0%
Value US$306,453
3.3
Okupe Oluyemi Chief Financial Officer Officer
Transaction date
Planned sale
Price
35.72
Quantity 23,090 -19.7%
Value US$824,710
3.3
Oluyemi Okupe Officer Officer
Transaction date
Proposed sale
Price
35.05
Quantity 32,160
Value US$1,127,208
0.5
Chi Michael Chief Operating Officer Officer
Transaction date
Planned sale
Price
36.71
Quantity 13,750 -4.3%
Value US$504,762
3.6
Carroll Patrick Harrison Chief Medical Officer Executive Director
Transaction date
Planned sale
Price
36.71
Quantity 10,021 -5.6%
Value US$367,871
2.4
Becklund Irene PAO Officer
Transaction date
Planned sale
Price
36.71
Quantity 8,411 -79.8%
Value US$308,768
1.8
Autor Deborah M. Chief Policy Officer Executive Director
Transaction date
Planned sale
Price
36.71
Quantity 7,054 -53.3%
Value US$258,952
3.6
Carroll Patrick Harrison Officer; Director Executive Director
Transaction date
Proposed sale
Price
36.71
Quantity 10,021
Value US$367,871
0.5
Chi Michael Officer Officer
Transaction date
Proposed sale
Price
36.71
Quantity 13,750
Value US$504,762
2.4
Becklund Irene Officer Officer
Transaction date
Proposed sale
Price
36.71
Quantity 8,411
Value US$308,768
1.8
Autor Deborah M. Officer; Director Executive Director
Transaction date
Proposed sale
Price
36.71
Quantity 7,054
Value US$258,952
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-29 2026-10-28 PlS Planned sale
3.3
Boughton Soleil

Chief Legal Officer

Officer
31,389 -20.0%
226.80
US$4,498,168 		31,389 -20.0% 226.80 US$4,498,168
2026-10-28 2026-10-28 PrS Proposed sale
3.3
Boughton Soleil

Officer

Officer
16,116
378.38
US$1,909,134 		16,116 378.38 US$1,909,134
2026-10-15 2026-10-14 PlS Planned sale
3.3
Boughton Soleil

Chief Legal Officer

Officer
4,084 -16.8%
473.08
US$34,934 		4,084 -16.8% 473.08 US$34,934
2026-10-14 2026-10-14 PrS Proposed sale
3.3
Boughton Soleil

Officer

Officer
3,461
29.06
US$100,577 		3,461 29.06 US$100,577
2026-10-02 2026-10-01 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
2,000 -0.8%
29.70
US$59,400 		2,000 -0.8% 29.70 US$59,400
2026-10-01 2026-10-01 PrS Proposed sale
3.3
Okupe Oluyemi

Officer

Officer
2,000
29.70
US$59,400 		2,000 29.70 US$59,400
2026-10-02 2026-09-30 PlS Planned sale
3.3
Boughton Soleil

Chief Legal Officer

Officer
3,461 -1.1%
29.17
US$100,957 		3,461 -1.1% 29.17 US$100,957
2026-09-30 2026-09-30 PrS Proposed sale
3.3
Boughton Soleil

Officer

Officer
3,461
29.17
US$100,957 		3,461 29.17 US$100,957
2026-09-23 2026-09-22 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
29,277 -11.0%
29.95
US$876,846 		29,277 -11.0% 29.95 US$876,846
2026-09-22 2026-09-22 PrS Proposed sale
3.3
Okupe Oluyemi

Officer

Officer
29,277
29.95
US$876,846 		29,277 29.95 US$876,846
2026-09-18 2026-09-17 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
12,313 -4.7%
28.82
US$354,861 		12,313 -4.7% 28.82 US$354,861
2026-09-17 2026-09-17 PrS Proposed sale
3.3
Okupe Oluyemi

Officer

Officer
12,313
28.82
US$354,861 		12,313 28.82 US$354,861
2026-09-17 2026-09-16 PlS Planned sale
3.3
Boughton Soleil

Chief Legal Officer

Officer
6,236 -2.0%
27.86
US$173,735 		6,236 -2.0% 27.86 US$173,735
2026-09-16 2026-09-16 PrS Proposed sale
3.3
Boughton Soleil

Officer

Officer
6,236
27.86
US$173,735 		6,236 27.86 US$173,735
2026-09-17 2026-09-15 PlS Planned sale
0.5
Chi Michael

Chief Operating Officer

Officer
14,027 -3.0%
28.39
US$398,227 		14,027 -3.0% 28.39 US$398,227
2026-09-17 2026-09-15 PlS Planned sale
Elshenawy Mohamed

CTO

Officer
7,954 -4.1%
28.39
US$225,814 		7,954 -4.1% 28.39 US$225,814
2026-09-15 2026-09-15 PrS Proposed sale
Elshenawy Mohamed

Officer

Officer
7,954
28.39
US$225,814 		7,954 28.39 US$225,814
2026-09-15 2026-09-15 PrS Proposed sale
0.5
Chi Michael

Officer

Officer
14,027
28.39
US$398,227 		14,027 28.39 US$398,227
2026-09-03 2026-09-02 PlS Planned sale
3.3
Boughton Soleil

Chief Legal Officer

Officer
3,458 -1.1%
28.33
US$97,965 		3,458 -1.1% 28.33 US$97,965
2026-09-02 2026-09-02 PrS Proposed sale
3.3
Boughton Soleil

Officer

Officer
3,458
28.33
US$97,965 		3,458 28.33 US$97,965
2026-08-20 2026-08-19 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
4,938 -1.8%
29.99
US$148,111 		4,938 -1.8% 29.99 US$148,111
2026-08-20 2026-08-19 PlS Planned sale
3.3
Boughton Soleil

Chief Legal Officer

Officer
25,111 -7.4%
27.55
US$691,808 		25,111 -7.4% 27.55 US$691,808
2026-08-19 2026-08-19 PrS Proposed sale
3.3
Boughton Soleil

Officer

Officer
25,111
27.55
US$691,808 		25,111 27.55 US$691,808
2026-08-20 2026-08-18 PlS Planned sale
1.8
Autor Deborah M.

Chief Policy Officer

Executive Director
16,773 -25.5%
27.85
US$467,128 		16,773 -25.5% 27.85 US$467,128
2026-08-18 2026-08-18 PrS Proposed sale
1.8
Autor Deborah M.

Officer; Director

Executive Director
16,773
27.85
US$467,128 		16,773 27.85 US$467,128
2026-08-18 2026-08-17 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
9,388 -3.4%
27.89
US$261,802 		9,388 -3.4% 27.89 US$261,802
2026-07-22 2026-07-22 PrS Proposed sale
2.1
Pendarvis Christiane

Former Director

Non-Executive Director
3,500
32.37
US$113,278 		3,500 32.37 US$113,278
2026-07-20 2026-07-17 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
7,163 -2.5%
31.99
US$229,168 		7,163 -2.5% 31.99 US$229,168
2026-07-07 2026-07-06 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
7,163 -2.5%
36.49
US$261,351 		7,163 -2.5% 36.49 US$261,351
2026-07-06 2026-07-06 PrS Proposed sale
3.3
Oluyemi Okupe

Officer

Officer
28,652
38.28
US$1,096,799 		28,652 38.28 US$1,096,799
2026-06-23 2026-06-22 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
18,197 -6.0%
34.03
US$619,217 		18,197 -6.0% 34.03 US$619,217
2026-08-18 2026-06-18 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
55,383 -19.5%
35.09
US$1,943,389 		55,383 -19.5% 35.09 US$1,943,389
2026-06-23 2026-06-18 S Sale
3.6
Carroll Patrick Harrison

Chief Medical Officer

Officer
23,726 -11.5%
35.00
US$830,410 		23,726 -11.5% 35.00 US$830,410
2026-06-18 2026-06-18 PrS Proposed sale
3.6
Carroll Patrick Harrison

Officer

Officer
23,726
35.00
US$830,410 		23,726 35.00 US$830,410
2026-06-17 2026-06-17 PlS Planned sale
2.4
Becklund Irene

PAO

Officer
4,490 -39.8%
31.50
US$141,435 		4,490 -39.8% 31.50 US$141,435
2026-06-17 2026-06-17 PlS Planned sale
0.5
Chi Michael

Chief Operating Officer

Officer
14,027 -3.1%
31.50
US$441,850 		14,027 -3.1% 31.50 US$441,850
2026-06-17 2026-06-17 PlS Planned sale
Elshenawy Mohamed

CTO

Officer
30,040 -22.9%
31.50
US$946,260 		30,040 -22.9% 31.50 US$946,260
2026-06-17 2026-06-17 PrS Proposed sale
2.4
Becklund Irene

Officer

Officer
4,490
31.50
US$141,435 		4,490 31.50 US$141,435
2026-06-17 2026-06-17 PrS Proposed sale
Elshenawy Mohamed

Officer

Officer
30,040
31.50
US$946,260 		30,040 31.50 US$946,260
2026-06-17 2026-06-17 PrS Proposed sale
0.5
Chi Michael

Officer

Officer
14,027
31.50
US$441,850 		14,027 31.50 US$441,850
2026-06-17 2026-06-16 PlS Planned sale
2.4
Becklund Irene

PAO

Officer
7,573 -40.2%
30.25
US$229,083 		7,573 -40.2% 30.25 US$229,083
2026-06-16 2026-06-16 PrS Proposed sale
2.4
Becklund Irene

Officer

Officer
7,573
30.25
US$229,083 		7,573 30.25 US$229,083
2026-05-26 2026-05-26 B Purchase
2.8
WELLS DAVID B
Non-Executive Director
48,400 +27.5%
24.24
US$1,172,974 		48,400 +27.5% 24.24 US$1,172,974
2026-05-19 2026-05-18 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
7,950 -2.9%
23.64
US$187,916 		7,950 -2.9% 23.64 US$187,916
2026-04-22 2026-04-20 PlS Planned sale
3.3
Boughton Soleil

Chief Legal Officer

Officer
9,463 -3.1%
30.00
US$283,890 		9,463 -3.1% 30.00 US$283,890
2026-04-22 2026-04-20 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
19,645 -7.0%
29.96
US$588,615 		19,645 -7.0% 29.96 US$588,615
2026-04-20 2026-04-20 PrS Proposed sale
3.3
Boughton Soleil

Officer

Officer
9,463
30.00
US$283,890 		9,463 30.00 US$283,890
2026-04-20 2026-04-17 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
18,005 -6.3%
27.83
US$501,158 		18,005 -6.3% 27.83 US$501,158
2026-04-20 2026-04-16 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
36,922 -11.6%
25.90
US$956,147 		36,922 -11.6% 25.90 US$956,147
2026-04-07 2026-04-06 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
3,975 -1.2%
19.98
US$79,409 		3,975 -1.2% 19.98 US$79,409
2026-04-06 2026-04-06 PrS Proposed sale
3.3
Oluyemi Okupe

Officer

Officer
240,560
20.33
US$4,890,585 		240,560 20.33 US$4,890,585
2026-03-24 2026-03-20 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
9,217 -2.8%
23.77
US$219,067 		9,217 -2.8% 23.77 US$219,067
2026-03-18 2026-03-17 PlS Planned sale
3.3
Boughton Soleil

Chief Legal Officer

Officer
4,812 -1.5%
24.69
US$118,808 		4,812 -1.5% 24.69 US$118,808
2026-03-18 2026-03-17 PlS Planned sale
2.4
Becklund Irene

PAO

Officer
5,529 -38.7%
24.69
US$136,511 		5,529 -38.7% 24.69 US$136,511
2026-03-18 2026-03-17 PlS Planned sale
0.5
Chi Michael

Chief Operating Officer

Officer
97,289 -19.3%
24.69
US$2,402,065 		97,289 -19.3% 24.69 US$2,402,065
2026-03-17 2026-03-17 PrS Proposed sale
3.3
Boughton Soleil

Officer

Officer
4,812
24.69
US$118,808 		4,812 24.69 US$118,808
2026-03-17 2026-03-17 PrS Proposed sale
2.4
Becklund Irene

Officer

Officer
5,529
24.69
US$136,511 		5,529 24.69 US$136,511
2026-03-17 2026-03-17 PrS Proposed sale
0.5
Chi Michael

Officer

Officer
97,289
24.69
US$2,402,065 		97,289 24.69 US$2,402,065
2026-03-02 2026-02-27 PlS Planned sale
3.3
Boughton Soleil

Chief Legal Officer

Officer
4,651 -1.0%
15.21
US$70,742 		4,651 -1.0% 15.21 US$70,742
2026-02-27 2026-02-27 PrS Proposed sale
3.3
Boughton Soleil

Officer

Officer
4,651
15.21
US$70,742 		4,651 15.21 US$70,742
2026-02-04 2026-02-03 S Sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
5,262 -5.4%
26.44
US$139,108 		5,262 -5.4% 26.44 US$139,108
2026-02-04 2026-02-03 S Sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
5,262 -5.4%
26.44
US$139,108 		5,262 -5.4% 26.44 US$139,108
2026-01-21 2026-01-20 S Sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
9,067 -9.0%
30.34
US$275,114 		9,067 -9.0% 30.34 US$275,114
2026-01-20 2026-01-20 PrS Proposed sale
3.3
Oluyemi Okupe

Officer

Officer
27,204
30.47
US$828,906 		27,204 30.47 US$828,906
2026-01-07 2026-01-05 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
9,070 -9.0%
33.79
US$306,453 		9,070 -9.0% 33.79 US$306,453
2025-12-23 2025-12-22 PlS Planned sale
3.3
Okupe Oluyemi

Chief Financial Officer

Officer
23,090 -19.7%
35.72
US$824,710 		23,090 -19.7% 35.72 US$824,710
2025-12-22 2025-12-22 PrS Proposed sale
3.3
Oluyemi Okupe

Officer

Officer
32,160
35.05
US$1,127,208 		32,160 35.05 US$1,127,208
2025-12-18 2025-12-17 PlS Planned sale
0.5
Chi Michael

Chief Operating Officer

Officer
13,750 -4.3%
36.71
US$504,762 		13,750 -4.3% 36.71 US$504,762
2025-12-18 2025-12-17 PlS Planned sale
3.6
Carroll Patrick Harrison

Chief Medical Officer

Executive Director
10,021 -5.6%
36.71
US$367,871 		10,021 -5.6% 36.71 US$367,871
2025-12-18 2025-12-17 PlS Planned sale
2.4
Becklund Irene

PAO

Officer
8,411 -79.8%
36.71
US$308,768 		8,411 -79.8% 36.71 US$308,768
2025-12-18 2025-12-17 PlS Planned sale
1.8
Autor Deborah M.

Chief Policy Officer

Executive Director
7,054 -53.3%
36.71
US$258,952 		7,054 -53.3% 36.71 US$258,952
2025-12-17 2025-12-17 PrS Proposed sale
3.6
Carroll Patrick Harrison

Officer; Director

Executive Director
10,021
36.71
US$367,871 		10,021 36.71 US$367,871
2025-12-17 2025-12-17 PrS Proposed sale
0.5
Chi Michael

Officer

Officer
13,750
36.71
US$504,762 		13,750 36.71 US$504,762
2025-12-17 2025-12-17 PrS Proposed sale
2.4
Becklund Irene

Officer

Officer
8,411
36.71
US$308,768 		8,411 36.71 US$308,768
2025-12-17 2025-12-17 PrS Proposed sale
1.8
Autor Deborah M.

Officer; Director

Executive Director
7,054
36.71
US$258,952 		7,054 36.71 US$258,952

See older Hims & Hers Health Inc insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Hims & Hers Health Inc history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Hims & Hers Health Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America